In addition, CBS contribution into the development of tumors and proliferation of malignant cells has been described for chronic myeloid leukemia [39] and breast [40], ovarian [41], and colon [42] cancer. This evidence concerns the gene CBS and chronic myelogenous leukemia, BCR-ABL1 positive.